Principal investigators’ experience of COVID-19 therapeutic clinical trials in Japan: a qualitative study
Objective During the COVID-19 pandemic, many clinical trials were conducted to identify effective COVID-19 therapeutics. However, while a large amount of resources was invested and significant numbers of patients participated, this did not necessarily have an impact on clinical practice. To face the...
Saved in:
| Main Authors: | Tatsuo Iiyama, Taro Shibata, Hiroki Saito, Satoko Horii, Miwa Sonoda, Kazuaki Jindai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/6/e097611.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in the spatiotemporal patterns of COVID-19 in Japan from 2020 through 2023
by: Atsuna Tokumoto, et al.
Published: (2025-05-01) -
Exploring perceptions of diabetes distress and its care in Japan: a qualitative study of patients and physicians
by: Kyoko Akano, et al.
Published: (2024-12-01) -
Investigation on railway investment-induced neighborhood change and local spatial spillover effects in Nagoya, Japan
by: Lisha Wang, et al.
Published: (2021-06-01) -
Survey on Professional Development and Maintenance of Vocational Rehabilitation Practitioners in Japan
by: Kazuaki MAEBARA
Published: (2025-04-01) -
Distribution status of genetically modified soybeans from the United States and Canada to Japan in 2021 and 2022
by: Keisuke Soga, et al.
Published: (2025-12-01)